Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 6/2016

01-06-2016 | Original Article

Elaboration of a clinical and paraclinical score to estimate the probability of herpes simplex virus encephalitis in patients with febrile, acute neurologic impairment

Authors: S. Gennai, A. Rallo, D. Keil, A. Seigneurin, R. Germi, O. Epaulard

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 6/2016

Login to get access

Abstract

Herpes simplex virus (HSV) encephalitis is associated with a high risk of mortality and sequelae, and early diagnosis and treatment in the emergency department are necessary. However, most patients present with non-specific febrile, acute neurologic impairment; this may lead clinicians to overlook the diagnosis of HSV encephalitis. We aimed to identify which data collected in the first hours in a medical setting were associated with the diagnosis of HSV encephalitis. We conducted a multicenter retrospective case–control study in four French public hospitals from 2007 to 2013. The cases were the adult patients who received a confirmed diagnosis of HSV encephalitis. The controls were all the patients who attended the emergency department of Grenoble hospital with a febrile acute neurologic impairment, without HSV detection by polymerase chain reaction (PCR) in the cerebrospinal fluid (CSF), in 2012 and 2013. A multivariable logistic model was elaborated to estimate factors significantly associated with HSV encephalitis. Finally, an HSV probability score was derived from the logistic model. We identified 36 cases and 103 controls. Factors independently associated with HSV encephalitis were the absence of past neurological history (odds ratio [OR] 6.25 [95 % confidence interval (CI): 2.22–16.7]), the occurrence of seizure (OR 8.09 [95 % CI: 2.73–23.94]), a systolic blood pressure ≥140 mmHg (OR 5.11 [95 % CI: 1.77–14.77]), and a C-reactive protein <10 mg/L (OR 9.27 [95 % CI: 2.98–28.88]). An HSV probability score was calculated summing the value attributed to each independent factor. HSV encephalitis diagnosis may benefit from the use of this score based upon some easily accessible data. However, diagnostic evocation and probabilistic treatment must remain the rule.
Literature
1.
go back to reference Mailles A, Stahl JP; Steering Committee and Investigators Group (2009) Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 49:1838–1847CrossRefPubMed Mailles A, Stahl JP; Steering Committee and Investigators Group (2009) Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 49:1838–1847CrossRefPubMed
2.
go back to reference Gordon B, Selnes OA, Hart J Jr, Hanley DF, Whitley RJ (1990) Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis. Arch Neurol 47:646–647CrossRefPubMed Gordon B, Selnes OA, Hart J Jr, Hanley DF, Whitley RJ (1990) Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis. Arch Neurol 47:646–647CrossRefPubMed
3.
go back to reference Klapper PE, Cleator GM (1998) European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis. Clin Microbiol Infect 4:178–180CrossRefPubMed Klapper PE, Cleator GM (1998) European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis. Clin Microbiol Infect 4:178–180CrossRefPubMed
4.
go back to reference Greenland S (2004) Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case–control studies. Am J Epidemiol 160:301–305CrossRefPubMed Greenland S (2004) Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case–control studies. Am J Epidemiol 160:301–305CrossRefPubMed
5.
go back to reference Raschilas F, Wolff M, Delatour F et al (2002) Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis 35:254–260CrossRefPubMed Raschilas F, Wolff M, Delatour F et al (2002) Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis 35:254–260CrossRefPubMed
6.
go back to reference Sili U, Kaya A, Mert A; HSV Encephalitis Study Group (2014) Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients. J Clin Virol 60:112–118CrossRefPubMed Sili U, Kaya A, Mert A; HSV Encephalitis Study Group (2014) Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients. J Clin Virol 60:112–118CrossRefPubMed
7.
go back to reference McGrath N, Anderson NE, Croxson MC, Powell KF (1997) Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry 63:321–326CrossRefPubMedPubMedCentral McGrath N, Anderson NE, Croxson MC, Powell KF (1997) Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry 63:321–326CrossRefPubMedPubMedCentral
8.
go back to reference Tan IL, McArthur JC, Venkatesan A, Nath A (2012) Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurology 79:2125–2132CrossRefPubMedPubMedCentral Tan IL, McArthur JC, Venkatesan A, Nath A (2012) Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurology 79:2125–2132CrossRefPubMedPubMedCentral
9.
go back to reference Chavanet P, Schaller C, Levy C et al (2007) Performance of a predictive rule to distinguish bacterial and viral meningitis. J Infect 54:328–336CrossRefPubMed Chavanet P, Schaller C, Levy C et al (2007) Performance of a predictive rule to distinguish bacterial and viral meningitis. J Infect 54:328–336CrossRefPubMed
10.
go back to reference Kulik DM, Uleryk EM, Maguire JL (2013) Does this child have bacterial meningitis? A systematic review of clinical prediction rules for children with suspected bacterial meningitis. J Emerg Med 45:508–519CrossRefPubMed Kulik DM, Uleryk EM, Maguire JL (2013) Does this child have bacterial meningitis? A systematic review of clinical prediction rules for children with suspected bacterial meningitis. J Emerg Med 45:508–519CrossRefPubMed
11.
go back to reference Thwaites GE, Chau TT, Stepniewska K et al (2002) Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 360:1287–1292CrossRefPubMed Thwaites GE, Chau TT, Stepniewska K et al (2002) Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 360:1287–1292CrossRefPubMed
12.
go back to reference Cohn KA, Thompson AD, Shah SS et al (2012) Validation of a clinical prediction rule to distinguish Lyme meningitis from aseptic meningitis. Pediatrics 129:e46–e53CrossRefPubMed Cohn KA, Thompson AD, Shah SS et al (2012) Validation of a clinical prediction rule to distinguish Lyme meningitis from aseptic meningitis. Pediatrics 129:e46–e53CrossRefPubMed
13.
go back to reference Lewthwaite P, Begum A, Ooi MH et al (2010) Disability after encephalitis: development and validation of a new outcome score. Bull World Health Organ 88:584–592CrossRefPubMedPubMedCentral Lewthwaite P, Begum A, Ooi MH et al (2010) Disability after encephalitis: development and validation of a new outcome score. Bull World Health Organ 88:584–592CrossRefPubMedPubMedCentral
Metadata
Title
Elaboration of a clinical and paraclinical score to estimate the probability of herpes simplex virus encephalitis in patients with febrile, acute neurologic impairment
Authors
S. Gennai
A. Rallo
D. Keil
A. Seigneurin
R. Germi
O. Epaulard
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 6/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2619-7

Other articles of this Issue 6/2016

European Journal of Clinical Microbiology & Infectious Diseases 6/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.